What does Virtus Investment Advisers, LLC hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

Virtus Investment Advisers, LLC filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

GILEAD SCIENCES INC

$3M20K0.8%

AMGEN INC

$3M8K0.8%

REGENERON PHARMACEUTICALS

$3M4K0.8%

IMMUNITYBIO INC

$3M358K0.8%

VERTEX PHARMACEUTICALS INC

$3M6K0.7%

INCYTE CORP

$3M27K0.7%

VERTIV HOLDINGS CO

$3M10K0.7%

ALNYLAM PHARMACEUTICALS INC

$2M7K0.7%

EDISON INTL

$2M33K0.7%

ROSS STORES INC

$2M10K0.6%

Filing history loading…